Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan

INTRODUCTION: Percutaneous hepatic perfusion (PHP) with melphalan is an effective treatment for patients with hepatic metastases, but associated with high rates of bone marrow depression. To reduce systemic toxicity, improvements have been made to the filtration system. In pre-clinical studies, the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cardiovasc Intervent Radiol
Main Authors: de Leede, Eleonora M., Burgmans, Mark C., Meijer, T. Susanna, Martini, Christian H., Tijl, Fred G. J., Vuyk, Jaap, van Erkel, Arian R., van der Velde, Cornelis J. H., Kapiteijn, Ellen, Vahrmeijer, Alexander L.
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2017
Assuntos:
Clinical Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5554291/
https://ncbi.nlm.nih.gov/pubmed/28451811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00270-017-1630-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares